EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cerebral Small Vessel Disease in Immune‐Mediated Thrombotic Thrombocytopenic Purpura Patients During the Acute Phase and Disease Remission

Addolorata Truma iD, Francesco Maria Lo Russo iD, Giorgio Conte iD, Ilaria Mancini, Andrea Artoni, Juri Alessandro Giannotta, Barbara Ferrari, Pasquale Agosti, Maria Abbattista, Matteo Gagliardi iD, Eleonora Piccin, Marco Stroppi und 2 weitere

American Journal of Hematology · 2026-12 · 101 (12) · 3001-3009

DOI: 10.1002/ajh.70506 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Hematology, online erschienen am 22.09.2026. Verfasst von Addolorata Truma und 13 weiteren Autor:innen. Beteiligte Einrichtung: Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy. Hauptthemen laut MEDLINE: Cerebral Small Vessel Diseases, Purpura, Thrombotic Thrombocytopenic. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute, Ministero dell'Università e della Ricerca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immune‐mediated thrombotic thrombocytopenic purpura (iTTP) is a life‐threatening thrombotic microangiopathy characterized by acute neurological manifestations and long‐term sequelae related to microvascular brain injury. Cerebral small vessel disease (cSVD), detectable on MRI through lacunes, microbleeds, white matter hyperintensities, and enlarged perivascular spaces, is a risk factor for stroke and cognitive decline, but its prevalence and evolution in iTTP are unknown. We conducted a prospective study of consecutive patients with acute iTTP and age‐matched controls to assess the prevalence and one‐year progression of cSVD. Brain MRI was performed at enrollment and repeated after 12–18 months in clinical remission. cSVD burden was quantified using a standardized 0–4 score based on four MRI markers. Twenty‐five patients (median age 56 years; 60% women) were enrolled. Acute focal ischemic lesions were detected in 13 (52%). cSVD was present in 48% of patients versus 27% of controls, while moderate burden (score ≥ 2) occurred in 24% versus none. Ordinal logistic regression showed an association between iTTP and higher cSVD scores (OR 3.19, 95% CI 1.00–10.14), independent of traditional cardiovascular risk factors. Follow‐up MRI was available in 22 patients (88%). In paired analyses, cSVD prevalence increased from 50% to 64%, moderate‐to‐high burden from 27% to 41%, and six patients (27%) showed score progression. At 1 year, patients had higher odds of greater cSVD burden than controls (age‐ and sex‐adjusted ordinal OR 7.00, 95% CI 1.65–29.74). These findings indicate that cSVD is common during acute iTTP and progresses during the first year despite hematological remission.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cerebral Small Vessel DiseasesPurpura, Thrombotic ThrombocytopenicHumansFemaleMaleMiddle AgedProspective StudiesAgedMagnetic Resonance ImagingAdultAcute DiseaseDisease ProgressionRisk FactorsPrevalenceRemission Induction

Autor:innen und Institutionen

  • Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy.
  • Neuroradiology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Department of Pathophysiology and Transplantation, Università Degli Studi di Milano, Milan, Italy.
  • Medical Physics Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

ORCID-Profile: Addolorata Truma, Francesco Maria Lo Russo, Giorgio Conte, Matteo Gagliardi, Flora Peyvandi

Förderung

  • Ministero della Salute
  • Ministero dell'Università e della Ricerca

Zitieren

APA

Truma, A., Russo, F. M. L., Conte, G., Mancini, I., Artoni, A., Giannotta, J. A., Ferrari, B., Agosti, P., Abbattista, M., Gagliardi, M., Piccin, E., Stroppi, M., Triulzi, F. M., & Peyvandi, F. (2026). Cerebral Small Vessel Disease in Immune‐Mediated Thrombotic Thrombocytopenic Purpura Patients During the Acute Phase and Disease Remission. American Journal of Hematology, 101(12), 3001-3009. https://doi.org/10.1002/ajh.70506

Vancouver

Truma A, Russo FML, Conte G, Mancini I, Artoni A, Giannotta JA, et al. Cerebral Small Vessel Disease in Immune‐Mediated Thrombotic Thrombocytopenic Purpura Patients During the Acute Phase and Disease Remission. American Journal of Hematology. 2026;101(12):3001-3009. doi:10.1002/ajh.70506

BibTeX
@article{Truma2026,
  author = {Truma, Addolorata and Russo, Francesco Maria Lo and Conte, Giorgio and Mancini, Ilaria and Artoni, Andrea and Giannotta, Juri Alessandro and Ferrari, Barbara and Agosti, Pasquale and Abbattista, Maria and Gagliardi, Matteo and Piccin, Eleonora and Stroppi, Marco and Triulzi, Fabio Maria and Peyvandi, Flora},
  title = {Cerebral Small Vessel Disease in Immune‐Mediated Thrombotic Thrombocytopenic Purpura Patients During the Acute Phase and Disease Remission},
  journal = {American Journal of Hematology},
  year = {2026},
  volume = {101},
  number = {12},
  pages = {3001--3009},
  doi = {10.1002/ajh.70506}
}
Kostenlos starten →